
Supported by an educational grant from:

Additional support from:

|
Day 3, 8th July 2006
Session 5: part 1
09.00 - 10.35
Treating the Clinical Consequences 1: Drug Dependence
Chair: G. Fischer (AT) |
09.00 |
Keynote address: Good Practice Requirements in the Treatment of Opioid Dependence |
A. Uchtenhagen (CH) |
| |
09.45 |
Attention Deficit Disorders in Adults and Cocaine Addiction |
|
| |
10:05 |
Standard of Opioid Therapy During Pregnancy |
G. Fischer (AT) |
| |
10.25 |
Discussion |
All |
Session 5: part 2
11.00 - 12.00
Treating the Clinical Consequences 1: Drug Dependence
Chair: G. Fischer (AT) |
| |
11.00 |
Pharmacotherapeutic approaches for the management of cocaine dependent patients |
F. Vocci (USA) |
| |
11.15 |
Ondensetron for the treatment of cocaine dependance |
B. Johnson (USA) |
| |
11.30 |
Bupropion for the Treatment of Methamphetamine Dependence |
A. Elkashef (USA) |
| |
11.45 |
Discussion |
ALL |
Session 6
12.00 - 14.00
Treating the Clinical Consequences 2: Alcoholism
Chair: M. Gossop (UK) |
12.00 |
Keynote address: Combining Medications and Behavioural Interventions for Alcohol Dependence |
S. O'Malley (USA) |
| |
12.45 |
Alcohol Problems in Accident & Emergency Departments |
R. Patton (UK) |
| |
13.05 |
Mysteries of recovery from alcohol use disorders: Mechanisms of behaviour change processes and relevance of individualised treatment. |
G. Büehringer (DE) |
| |
13.25 |
The UK Alcohol Treatment Trial |
G. Tober (UK) |
| |
13.45 |
Discussion |
All |
|
|
|